Purdue's 'Duplicative' Suit Over OxyContin Generic Gets Ax
Tweaks to a generic opioid's labeling did not warrant OxyContin maker Purdue Pharma LP to file a separate lawsuit repeating extant patent infringement claims, a federal judge decided in a Boston...To view the full article, register now.
Already a subscriber? Click here to view full article